Gene · 6709
Papers1,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Characterization of RNA Profiles in Processing Bodies of Embryonic Stem Cells and Mesodermal Cells. | Genomics Proteomics Bioinformatics | 2026 | 42671352 | PubTator, text mining | PubMed |
| Antisense oligonucleotides treatment uncovers differences in the modulation of dysregulated intracellular pathways in Spinal Muscular Atrophy motoneurons. | Cell Death Dis | 2026 | 42443163 | PubTator, text mining | PubMed |
| Elucidating the Role of SET as a Key Contributor to Neurodevelopmental Disability Within the 9q34.11 Deletion Syndrome Interval. | Clin Genet | 2026 | 42432431 | PubTator, text mining | PubMed |
A Dose-Response Study on Human FGF21 to Inhibit Necrosis, Spectrin Breakdown, and to Increase Intracellular Cold Shock Proteins in Cultured Cortical Neurons Subjected to Oxygen-Glucose Deprivation Injury. | Mol Neurobiol | 2026 | 42387004 | PubTator, text mining | PubMed |
| Role of Spatial Heterogeneity in Muscle-Invasive Bladder Cancer on Overall Survival and Immunotherapy Response. | Cancers (Basel) | 2026 | 41827808 | PubTator, text mining | PubMed |
| Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. | J Inflamm Res | 2026 | 41798638 | PubTator, text mining | PubMed |
| Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | 41797662 | PubTator, text mining | PubMed |
| Neurodegeneration Biomarkers in Epilepsy: A Critical Review of Current Findings. | Life (Basel) | 2026 | 41752932 | PubTator, text mining | PubMed |
| Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. | Genes (Basel) | 2026 | 41751517 | PubTator, text mining | PubMed |
| Deciphering the Impact of RAC1-SPTAN1 in ARPKD Cystogenesis Using Multifaceted Models. | Adv Sci (Weinh) | 2026 | 41742835 | PubTator, text mining | PubMed |
| Comprehensive analysis of the potential effect and mechanism of pyroptosis-related genes in treatment-related myeloid tumors. | PLoS One | 2026 | 41734196 | PubTator, text mining | PubMed |
| Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia. | Nat Commun | 2026 | 41690933 | PubTator, text mining | PubMed |
| A shear stress-responsive pathway in monocytes drives cardiopulmonary bypass-induced inflammation via spectrin/RAF1/store-operated calcium entry. | Cell Rep | 2026 | 41579376 | PubTator, text mining | PubMed |
| Spectrin condensates provide a nidus for assembling the axonal membrane-associated periodic skeleton. | iScience | 2026 | 41536998 | PubTator, text mining | PubMed |
| Unveiling dry eye with autoimmune features (DEAF): insights from a prospective longitudinal study. | Clin Rheumatol | 2026 | 41528637 | PubTator, text mining | PubMed |
| 9q34.11 Microduplications Encompassing SET Gene Are Associated With Neurodevelopmental Disorder and Recurrent Dysmorphisms. | Am J Med Genet A | 2026 | 41267543 | PubTator, text mining | PubMed |
| Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome. | J Proteomics | 2026 | 41260331 | PubTator, text mining | PubMed |
| Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression. | Adv Sci (Weinh) | 2026 | 41243220 | PubTator, text mining | PubMed |
| A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy. | Eur J Hum Genet | 2026 | 40999194 | PubTator, text mining | PubMed |
| Novel SPTAN1 variant mimicking hereditary spastic paraplegia (HSP). | BMJ Case Rep | 2025 | 41338915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6709/papers